Delivery Order SPE2DB22D2206-SPE2DB25FJE52
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Orencia 125 mg/ml syringes with a ceiling value of $8,140.49. This firm fixed-price delivery order represents a non-set-aside competitive award and is expected to be completed by July 23, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, with a contract ceiling value of $14,863.40. The award, issued on July 30, 2025, is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025. This non-competitive set-aside award represents a specific pharmaceutical procurement from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place...
- The Defense Logistics Agency awarded a delivery order valued at $10,782.12 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,282.52 firm fixed-price delivery order is for the supply of Orencia 125 mg/ml syringes, a medication used to treat various autoimmune conditions. The contract has an ultimate completion date of May 14, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- The Defense Logistics Agency awarded a $24,175.31 delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, with an ultimate completion date of August 1, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and supplies brand-name medications, generic drugs, vaccines,...
- This federal contract award, valued at $41,177.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Orencia 125 mg/ml syringes, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,313.48 firm-fixed-price contract is for the supply of Orencia 125 mg/mL syringes, with a completion date of November 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,445.34 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used in the treatment of rheumatoid arthritis. This firm fixed price delivery order, issued on July 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,541.68 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, issued on July 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded on March 5, 2024, is for the delivery of Orencia 125 mg/ml syringes, with a ceiling value of $3,632.50 and a completion date of March 6, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJE52Delivery Order
AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) for Orencia 125 mg/mL syringes valued at $8,646.31. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, under firm fixed pricing with no set-aside designation. This delivery order represents a competitively awarded transaction processed through the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This contract is a child order under AmerisourceBergen's broader $999,999,999 IDC with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The IDC enables AmerisourceBergen to supply a diverse portfolio of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The delivery order for Orencia, a prescription biologic used primarily for rheumatoid arthritis treatment, demonstrates the company's role in supplying critical therapeutic medications to military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 7/31/25 |